Literature DB >> 19411456

Heterotopic ossification in high-energy wartime extremity injuries: prevalence and risk factors.

Jonathan Agner Forsberg1, Joseph M Pepek, Scott Wagner, Kevin Wilson, James Flint, Romney C Andersen, Doug Tadaki, Frederick A Gage, Alexander Stojadinovic, Eric A Elster.   

Abstract

BACKGROUND: Heterotopic ossification in the extremities remains a common complication in the setting of high-energy wartime trauma, particularly in blast-injured amputees and in those in whom the definitive amputation was performed within the zone of injury. The purposes of this cohort study were to report the experience of one major military medical center with high-energy wartime extremity wounds, to define the prevalence of heterotopic ossification in these patients, and to explore the relationship between heterotopic ossification and other potential independent predictors.
METHODS: We retrospectively reviewed the records and radiographs of all combat-wounded patients admitted to this institution between March 1, 2003, and December 31, 2006. Patients with a minimum of two months of radiographic follow-up who underwent at least one orthopaedic procedure on an extremity constituted our study group; those who underwent at least one orthopaedic procedure but had not had heterotopic ossification develop constituted the control group. Variables recorded for each study subject included age and sex, location and mechanism of injury, method(s) of fracture fixation, number of débridement procedures, duration of negative pressure therapy, location of heterotopic ossification, presence and severity of traumatic brain injury, and Injury Severity Scores.
RESULTS: During the study period, 1213 war-wounded patients were admitted. Of those patients, 243 (157 in the heterotopic ossification group and eighty-six controls) met the inclusion criteria. The observed rate of heterotopic ossification was 64.6%. A significant relationship was detected between heterotopic ossification and the presence (p = 0.006) and severity (p = 0.003) of a traumatic brain injury. Risk factors for the development of heterotopic ossification were found to be an age of less than thirty years (p = 0.007, odds ratio = 3.0), an amputation (p = 0.048, odds ratio = 2.9), multiple extremity injuries (p = 0.002, odds ratio = 3.9), and an Injury Severity Score of >or=16 (p = 0.02, odds ratio = 2.2).
CONCLUSIONS: The prevalence of heterotopic ossification in war-wounded patients is higher than that in civilian trauma. Although trends associated with local wound conditions were identified, the risk factors for the development of heterotopic ossification found in this study suggest that systemic causes predominate.

Entities:  

Mesh:

Year:  2009        PMID: 19411456     DOI: 10.2106/JBJS.H.00792

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  91 in total

1.  Fibrodysplasia ossificans progressiva: a human genetic disorder of extraskeletal bone formation, or--how does one tissue become another?

Authors:  Eileen M Shore
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012 Jan-Feb       Impact factor: 5.814

2.  Osteogenic potential of alpha smooth muscle actin expressing muscle resident progenitor cells.

Authors:  Brya G Matthews; Elena Torreggiani; Emilie Roeder; Igor Matic; Danka Grcevic; Ivo Kalajzic
Journal:  Bone       Date:  2015-12-22       Impact factor: 4.398

3.  What Risk Factors Predict Recurrence of Heterotopic Ossification After Excision in Combat-related Amputations?

Authors:  Gabriel J Pavey; Elizabeth M Polfer; Kyle E Nappo; Scott M Tintle; Jonathan A Forsberg; Benjamin K Potter
Journal:  Clin Orthop Relat Res       Date:  2015-09       Impact factor: 4.176

4.  Strategic Targeting of Multiple BMP Receptors Prevents Trauma-Induced Heterotopic Ossification.

Authors:  Shailesh Agarwal; Shawn J Loder; Christopher Breuler; John Li; David Cholok; Cameron Brownley; Jonathan Peterson; Hsiao H Hsieh; James Drake; Kavitha Ranganathan; Yashar S Niknafs; Wenzhong Xiao; Shuli Li; Ravindra Kumar; Ronald Tompkins; Michael T Longaker; Thomas A Davis; Paul B Yu; Yuji Mishina; Benjamin Levi
Journal:  Mol Ther       Date:  2017-07-15       Impact factor: 11.454

5.  Osteogenic gene expression correlates with development of heterotopic ossification in war wounds.

Authors:  Korboi N Evans; Benjamin K Potter; Trevor S Brown; Thomas A Davis; Eric A Elster; Jonathan A Forsberg
Journal:  Clin Orthop Relat Res       Date:  2013-10-18       Impact factor: 4.176

6.  Sensory nerve induced inflammation contributes to heterotopic ossification.

Authors:  Elizabeth Salisbury; Eric Rodenberg; Corinne Sonnet; John Hipp; Francis H Gannon; Tegy J Vadakkan; Mary E Dickinson; Elizabeth A Olmsted-Davis; Alan R Davis
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

7.  Does Blast Medium Affect Heterotopic Ossification in a Blast-amputation Model?

Authors:  David E Jaffe; David Yoo; Jason Blevins; Gregory Gasbarro; Tyler Hughes; Ebrahim Paryavi; Thao Nguyen; William L Fourney; Vincent D Pellegrini
Journal:  Clin Orthop Relat Res       Date:  2015-04-28       Impact factor: 4.176

8.  Preventing Heterotopic Ossification in Combat Casualties-Which Models Are Best Suited for Clinical Use?

Authors:  Keith A Alfieri; Benjamin K Potter; Thomas A Davis; Matthew B Wagner; Eric A Elster; Jonathan A Forsberg
Journal:  Clin Orthop Relat Res       Date:  2015-09       Impact factor: 4.176

Review 9.  Multimodality imaging review of the post-amputation stump pain.

Authors:  Nawaraj Subedi; Priam Heire; Vinay Parmer; Simon Beardmore; Chooi Oh; Fergus Jepson; Syed I Ali
Journal:  Br J Radiol       Date:  2016-09-29       Impact factor: 3.039

10.  Risk factors for the development of heterotopic ossification in seriously burned adults: A National Institute on Disability, Independent Living and Rehabilitation Research burn model system database analysis.

Authors:  Benjamin Levi; Prakash Jayakumar; Avi Giladi; Jesse B Jupiter; David C Ring; Karen Kowalske; Nicole S Gibran; David Herndon; Jeffrey C Schneider; Colleen M Ryan
Journal:  J Trauma Acute Care Surg       Date:  2015-11       Impact factor: 3.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.